COVID-19 | Specialty

The OncLive COVID-19 condition center page is a comprehensive resource for clinical news and expert insights on how the COVID-19 pandemic has impacted multiple areas of oncology care and practice. This page features news articles, interviews in written and video format, and podcasts encompassing data of patients with COVID-19 and cancer, oncology drugs being tested against the virus, vaccine information for patients with cancer, and more.

COVID-19 Pandemic Accelerates RWD-Based Initiatives in Oncology

June 23rd 2020

The FDA is presently spearheading several initiatives in light of COVID-19 aimed at refining the role of RWD in cancer care to guide clinical trial development, procure answers to pressing clinical questions, and support regulatory decisions for in vitro diagnostics.

Breast Cancer Surgical Space Adapts in Response to COVID-19 Crisis, Prepares for Lockdowns to Lift

June 20th 2020

Eric Brown, MD, FACS, discusses how breast oncologists and surgeons have adapted to overcome the challenges presented by COVID-19 and continue to deliver the best care to patients as the United States begins to re-open.

Mild COVID-19 Symptoms Are Associated with Poorer Outcomes in Sickle Cell Disease

June 14th 2020

Results from a survey of patients in the United Kingdom showed patients with sickle cell disease diagnosed with COVID-19 and who had mild symptoms were more likely to die or require mechanical ventilation than those with more severe symptoms of COVID-19.

Long After COVID-19, Telemedicine Is Here to Stay in Oncology Practice

June 9th 2020

Andrew M. Evens, DO, MSc, discusses the telemedicine initiatives that have been taken at RCINJ—even before the COVID-19 outbreak—as well as proper telemedicine etiquette and best practices for oncologists getting a handle on the new approach in clinical practice.

Exploring New Treatment Options In HCC

June 8th 2020

This Onclive® webinar will focus on best practices and multidisciplinary approaches in the management of hepatocellular carcinoma and the impact of the COVID-19 pandemic on treatment selection in patients with HCC. Join us Thursday, June 23, 2020 at 8 PM EST.

Dr. McKay on Adapting Treatment for Patients With Cancer in COVID-19 Era

June 3rd 2020

Rana R. McKay, MD, discusses adapting treatment for patients with cancer during the coronavirus disease 2019 pandemic.

Dr. Scagliotti on Preventive Measures to Reduce COVID-19 Risk in Oncology

June 2nd 2020

Giorgio Vittorio Scagliotti, MD, PhD, discusses the precautionary measures implemented in clinical practice to protect patients with cancer from COVID-19.

Pandemic Poses a Crucial Moment for Science and the Public Trust

June 2nd 2020

At this moment, we should consider what it will take for the scientific community as a collective entity to self-regulate far more forcefully so that the actions of a limited number of its members do not squander the well-deserved awakening of public trust in the entire scientific enterprise.

Chowdhary Covers Risk-Reducing Strategies and Recommendations During the COVID-19 Era

June 2nd 2020

Mudit Chowdhary, MD, shares advice for family members living with patients with cancer, projects the long-term implications of the COVID-19 pandemic on clinical practice, provides insight on the effects of investigational treatments for patients with COVID-19, and details the protocols Rush University Medical Center has put into place to limit the spread of the virus.

Recent Chemotherapy Raises COVID-19-Related Mortality Risk for Patients With Thoracic Cancer

May 29th 2020

Chemotherapy administered within 3 months of a diagnosis of COVID-19 increased the risk of death in patients with thoracic cancer.

Active Cancer Strongly Associated With Increased COVID-19 Mortality

May 29th 2020

An analysis of data collected in the COVID-19 and Cancer Consortium registry showed that patients with progressive cancer were 5.2-times more likely to die within 30 days of being diagnosed with novel coronavirus 19 compared with patients in remission or with no evidence of disease.

Dr. Savvides on the Risk of COVID-19 in Patients With Cancer

May 27th 2020

Panayiotis S. Savvides, MD, discusses COVID-19 precautions for patients with lung cancer.

Telehealth Safely Connects Oncology Community During COVID-19 Crisis

May 26th 2020

Raymond Liu, MD, shed light on the benefits and challenges of utilizing telehealth in oncology and shared advice on how to implement this approach in practice.

Dr. Burris and Dr. Graff Talk COVID-19 and Cancer Care, Telemedicine, and ASCO Initiatives

May 25th 2020

Howard A. "Skip" Burris, III, MD, FASCO, FACP, and Stephanie L. Graff, MD, discuss how the COVID-19 pandemic has affected cancer care, the collaborative efforts made between Sarah Cannon Research Institute and HCA to increase access to investigational COVID-19 treatments, and the steps ASCO has taken to ensure its members’ professional education and well-being during this time.

Mindful Adaptation of Breast Cancer Treatment Necessary Amid COVID-19 Crisis

May 24th 2020

Although little evidence exists with regard to how to best treat patients with breast cancer during the COVID-19 pandemic, guidelines have been issued by organizations like ESMO to assist providers with making those decisions.

Dr. Thawani on AEs With Radiation Versus COVID-19 Symptoms in Lung Cancer

May 23rd 2020

Nitika Thawani, MD, discusses identifying the difference between adverse events that are associated with radiation versus COVID-19 symptoms in lung cancer.

Seattle Cancer Care Alliance Releases Guidance for Managing Hematologic Malignancies During COVID-19 Crisis

May 18th 2020

Mary-Beth Percival, MD, provides insight into precautionary measures put into place to ensure patient safety, some of the considerations included in the paper, and the different ways in which she is overcoming challenges faced in practice in light of the pandemic.

Dr. Huh on SGO COVID-19 Task Force Efforts

May 15th 2020

Warner K. Huh, MD, discusses some of the key challenges faced in the management of gynecologic cancers in light of the COVID-19 crisis, shares some of the resources provided by the SGO COVID-19 task force, and projects what is needed to quell the pandemic, which he refers to as version of the Great Depression.

Dr. Trent on the Impact of COVID-19 on the Treatment of Rare Cancers

May 13th 2020

Jonathan C. Trent, MD, PhD, sheds light on the impact of COVID-19 on the treatment of rare cancers.

Outreach and Grassroots Initiatives Augment the Fight Against COVID-19

May 12th 2020

Allyson Ocean, MD, discusses some of the key initiatives that she has helped spearhead to raise awareness on COVID-19 and provide PPE to those who need it.